These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 8899698

  • 1. Alzheimer's disease: new pharmacological perspectives.
    Palacios JM.
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():67-8. PubMed ID: 8899698
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Alzheimer's disease. Foreword].
    Derquesné C.
    Rev Prat; 1998 Nov 01; 48(17):1871-2. PubMed ID: 9882238
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease.
    Crismon ML.
    Pharmacotherapy; 1998 Nov 01; 18(2 Pt 2):47-54; discussion 79-82. PubMed ID: 9543465
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease.
    Prescrire Int; 2003 Dec 01; 12(68):230-1. PubMed ID: 14986699
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New therapeutic approaches to cognitive impairment.
    Schneider LS.
    J Clin Psychiatry; 1998 Dec 01; 59 Suppl 11():8-13. PubMed ID: 9731544
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of cholinesterase inhibitors for treatment of Alzheimer disease.
    Hake AM.
    Cleve Clin J Med; 2001 Jul 01; 68(7):608-9, 613-4, 616. PubMed ID: 11453078
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
    Prasher VP.
    Int J Geriatr Psychiatry; 2004 Jun 01; 19(6):509-15. PubMed ID: 15211527
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The new cholinesterase inhibitors for Alzheimer's disease, Part 1: their similarities are different.
    Stahl SM.
    J Clin Psychiatry; 2000 Oct 01; 61(10):710-1. PubMed ID: 11078030
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adherence to cholinesterase inhibitors in patients with Alzheimer's disease.
    Blais L, Kettani FZ, Perreault S, Leroux JC, Forget A, Kergoat MJ.
    J Am Geriatr Soc; 2009 Feb 01; 57(2):366-8. PubMed ID: 19207161
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.